HRSA-21-130: State Systems Development Initiative - Maternal Health Enhancement Supplement
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants of up to $60,000 to the applicants described in the notice. It expected to make about 15 awards worth $900,000 in total. Applications closed on July 2, 2021.
From the official notice on Grants.gov, last changed June 14, 2021. Checked November 7, 2026.
- Award ceiling$60,000
- Total funding$900,000
- Expected awards15
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | May 28, 2021 |
|---|---|
| Deadline | July 2, 2021 |
| Archived by Grants.gov | August 31, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Current recipients funded under the State Systems Development Initiative Grant Program (HRSA-18-061 and HRSA-18-062) are eligible to apply for supplemental funding under this program.
Is this a realistic fit?
- Past Special Projects of Regional and National Significance awards averaged $1.6 million; this notice allows up to $60,000 per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for supplemental funding under the State Systems Developmental Initiative (SSDI) Grant Program in support of MCHB’s Alliance for Innovation on Maternal Health (AIM) program. The purpose of this program is to expand state and jurisdictional maternal child health (MCH) data capacity in an effort to improve reporting for the AIM program, resulting in enhanced high quality and timely data and analysis. This funding opportunity will provide support to a subset (up to 15 of the 42) of SSDI award recipients whose state or jurisdiction is currently enrolled in the AIM program and participating in quality improvement (QI) via implementation of patient safety bundles within birthing facilities. Funds will be used to support the submission of timely, high quality maternal health data into the AIM Data Portal to support state and jurisdictional AIM QI activities. The SSDI – Maternal Health Enhancement Supplement program seeks to: • Expand state and jurisdictions’ MCH data capacity by utilizing Title V/MCH data analytic support to assist with AIM QI efforts and enhance data-driven decision making to improve maternal health care; • Improve the quality, validity, and timeliness of maternal health data at the state and jurisdictional levels; and, • Enhance the collection and use of data on race, ethnicity and social determinants to assess the impact of the AIM program on health equity and health disparities. MCHB recognizes the need to provide additional funding to expand MCH data capacity for up to 15 of the 42 states and jurisdictions that participate in both the SSDI and the AIM programs. Based upon the quality of data that has been submitted from states participating in AIM, MCHB is targeting additional support for a subset of states and jurisdictions to address MCH data capacity needs to more effectively support AIM patient safety bundle implementation efforts. These funds will specifically support states and jurisdictions to expand MCH data capacity to improve reporting for the AIM program, resulting in enhanced high quality and timely data and analysis of maternal health process and outcome data in support of AIM QI activities.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-21-130 still open?
No. It closed on July 2, 2021. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for State Systems Development Initiative - Maternal Health Enhancement Supplement?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for State Systems Development Initiative - Maternal Health Enhancement Supplement?
Closed July 2, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $60,000 each. About $900,000 in total across about 15 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)